News

Articles

Thermo Fisher Scientific has expanded its state-of-the-art R&D facility in Hyderabad, India.

Thermo Fisher Scientific Expands R&D Facility in India

Catalent will invest $350 million into integrated biologics drug substance and drug product manufacturing at Bloomington, Indiana facility.

Catalent to Invest $350 Million in Manufacturing Facility in Bloomington, Indiana

Otsuka Pharmaceutical and Osaka University have entered an exclusive license agreement on a new anti-tumor antibody.

Otsuka Pharmaceutical and Osaka University Enter Exclusive License Agreement 

Thermo Fisher Scientific has launched its first GMP-manufactured Cas9 protein for clinical genome editing research.

Thermo Fisher Scientific Launches New GMP-manufactured Cas9 Protein

High Purity New England has launched its third facility, focused on single-use assemblies.

High Purity New England Launches Third Facility

ReiThera and Exothera are collaborating to develop a large-scale, low-cost-per-dose manufacturing process to deliver novel vaccines to low and middle-income countries.

ReiThera and Exothera Collaborate on Manufacturing Vaccines for Low and Middle-income Countries

Achilles Therapeutics has announced that it will expand its clinical manufacturing capabilities in the UK and enter a partnership agreement for expansion in the US.

Achilles Therapeutics Announces Manufacturing Expansion in the UK and US

Evonetix’s thermally controlled DNA synthesis technology is designed to enable highly parallel DNA synthesis in a benchtop platform.

Evonetix Receives Patent for Thermally-Controlled DNA Synthesis Technology

INCOG Biopharma has completed the construction of its cleanroom production area, marking a milestone in the completion of an overall $100 million investment in a new facility. 

INCOG Biopharma Completes Construction of Cleanroom Production Area

Catalent has acquired the Vaccine Manufacturing Innovation Centre in Harwell, Oxford to expand its biologics capabilities across the UK and Europe.

Supplier News